A combination of actions of a plant-based compound, kaempferol, and miR activity modulation was also demonstrated for the recently described miR-339-5p-hnRNPA1/PTBP1-PKM2 axis, which inhibits glycolysis and CRC growth. This evidence concerns the gene PKM and colorectal carcinoma.